The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.

Autor: Bao KKH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Sutanto L; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Tse SSW; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Man Cheung K; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Chan JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Nov 01; Vol. 4 (11), pp. e2133132. Date of Electronic Publication: 2021 Nov 01.